BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9655978)

  • 21. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.
    Robertson GP; Furnari FB; Miele ME; Glendening MJ; Welch DR; Fountain JW; Lugo TG; Huang HJ; Cavenee WK
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9418-23. PubMed ID: 9689095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN and prostate cancer.
    Facher EA; Law JC
    J Med Genet; 1998 Sep; 35(9):790. PubMed ID: 9733047
    [No Abstract]   [Full Text] [Related]  

  • 23. PTEN germ-line mutations in juvenile polyposis coli.
    Olschwang S; Serova-Sinilnikova OM; Lenoir GM; Thomas G
    Nat Genet; 1998 Jan; 18(1):12-4. PubMed ID: 9425889
    [No Abstract]   [Full Text] [Related]  

  • 24. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
    Wang SI; Parsons R; Ittmann M
    Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
    Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
    Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PTEN: a tumor suppressor with original properties].
    Roux P
    Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cells. PTEN--coupling tumor suppression to stem cells?
    Penninger JM; Woodgett J
    Science; 2001 Dec; 294(5549):2116-8. PubMed ID: 11739945
    [No Abstract]   [Full Text] [Related]  

  • 32. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.
    Bose S; Wang SI; Terry MB; Hibshoosh H; Parsons R
    Oncogene; 1998 Jul; 17(1):123-7. PubMed ID: 9671321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pten is essential for embryonic development and tumour suppression.
    Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi PP
    Nat Genet; 1998 Aug; 19(4):348-55. PubMed ID: 9697695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
    Maxwell GL; Risinger JI; Tong B; Shaw H; Barrett JC; Berchuck A; Futreal PA
    Gynecol Oncol; 1998 Jul; 70(1):13-6. PubMed ID: 9698466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung.
    Petersen S; Rudolf J; Bockmühl U; Gellert K; Wolf G; Dietel M; Petersen I
    Oncogene; 1998 Jul; 17(4):449-54. PubMed ID: 9696038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
    Okami K; Wu L; Riggins G; Cairns P; Goggins M; Evron E; Halachmi N; Ahrendt SA; Reed AL; Hilgers W; Kern SE; Koch WM; Sidransky D; Jen J
    Cancer Res; 1998 Feb; 58(3):509-11. PubMed ID: 9458098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.